Takeda Ventures
Investor profile
Corporate VC
Takeda Ventures has backed 6 European tech companies across 8 funding rounds between 2005 and 2025, joining rounds totalling €76M. Most active in Healthtech and Fintech. Data as of Nov 2026.
Deals
8
distinct rounds
Companies
6
backed
Active span
2005–2025
21 yrs
Total round €
€76M
sum of rounds joined
Deals by year
distinct rounds / yearTakeda Ventures — deals by year — interactive chart.
Data table
| Takeda Ventures — deals by year | |
|---|---|
| 2005 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Top sectors
by dealsTakeda Ventures — top sectors — interactive chart.
Data table
| Takeda Ventures — top sectors | |
|---|---|
| Healthtech | 8 |
| Fintech | 1 |
Stages
by dealsTakeda Ventures — stages — interactive chart.
Data table
| Takeda Ventures — stages | |
|---|---|
| Other | 3 |
| Series A | 2 |
| Early VC | 1 |
| Seed | 1 |
| Series D+ | 1 |
Countries
by dealsTakeda Ventures — countries — interactive chart.
Data table
| Takeda Ventures — countries | |
|---|---|
| Belgium | 2 |
| Spain | 2 |
| Denmark | 1 |
| Israel | 1 |
| Netherlands | 1 |
| Norway | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- AdBio partners1
- Advent France Biotechnology1
- CDTI Innvierte1
- Columbus Venture Partners1
- Demcon Investment1
- Dutch Government1
- EIC Fund1
- Essex Woodlands Health Ventures1
- Gilde Healthcare1
- i&i Biotech Fund1
- Innovation SBI Japan-Israel Innovation Fund1
- Invivo Capita I1
- Invivo Capital Partners1
- Johnson & Johnson1
- Mirae Asset Venture Investment1
- Novalis Biotech1
- Novo A1
- Oost NL1
- OrbiMed1
- S1
- Seventure Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| BiomX | Israel | 1 | €22M |
| Symphogen | Denmark | 1 | €21M |
| Integra Therapeutics | Spain | 2 | €15M |
| Enzyre | Netherlands | 1 | €12M |
| Univercells | Belgium | 2 | €6.0M |
| Zelluna Immunotherapy | Norway | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| BiomX | Series A | €22M | 2017-05 |
| Symphogen | Series D+ | €21M | 2006-01 |
| Enzyre | Series A | €12M | 2022-11 |
| Integra Therapeutics | Seed | €11M | 2025-09 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Univercells | Other | €3.0M | 2017-04 |
| Univercells | Early VC | €3.0M | 2015-10 |